Dr. Siegfried Bialojan, Ernst & Young, about the significance of artificial intelligence for biotechnology

Dr. Siegfried Bialojan, Ernst & Young, about the significance of artificial intelligence for biotechnology

Dr. Siegfried Bialojan, Ernst & Young Executive Director and Head Life Science Center Mannheim stressed at the presentation of this year's German Biotechnology Report of EY on 14 June 2016 in Hamburg the significance of artificial intelligence for biotechnology:
"The field of artificial intelligence is about bringing together knowledge from endless sources of varying quality in order to produce self-learning systems - which will certainly lead to applications in biotechnology."

Comments are closed.